The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Chronic Kidney Disease Global Market Report 2023, the chronic kidney disease market is expected to show significant growth in the forecast period.

Chronic Kidney Disease (CKD) is a growing global health concern affecting millions of individuals. This blog post takes you through the key insights and trends in the Chronic Kidney Disease Global Market Report for 2023.

Rising Chronic Kidney Disease Market Growth
The global CKD market is on a significant upswing. In 2022, it reached $61.51 billion and is projected to expand to $65.74 billion in 2023, marking a robust CAGR of 6.9%. Looking ahead, the market is poised for continued growth, with an estimated size of $82.96 billion by 2027, at a CAGR of 6%.

The Prevalence of Kidney Disease
Kidney diseases encompass a group of conditions affecting the function and structure of the kidneys. Medications play a crucial role in managing these conditions by controlling blood pressure, reducing protein loss, and mitigating kidney impairment progression. This aids in symptom management and prevents severe consequences. In the United States, for example, the Centers for Disease Control and Prevention reported that 15% of the population, roughly 37 million people, were affected by kidney disease in July 2022. Additionally, a report from the Australian Institute of Health and Welfare indicated a rise in the prevalence of kidney replacement therapy from 94 (per 100,000 population) in 2019 to 95.4 (per 100,000 population) in 2020.

The high prevalence of kidney diseases underscores the demand for effective treatments and the need for ongoing innovation in the industry.

Embracing Product Innovations In The Chronic Kidney Disease Market
One notable trend in the CKD market is the increasing emphasis on product innovation. Companies in this sector are actively developing innovative products to maintain their foothold in the market. For instance, in August 2022, Bayer, a renowned German biotechnology and pharmaceutical company, introduced Kerendia (finerenone). This innovative medicine is designed to slow down the progression of CKD in diabetes patients. It stands out as a first-in-class, non-steroidal, selective mineralocorticoid receptor antagonist, differentiating it from existing treatments. By blocking mineralocorticoid receptor (MR) overactivation, it effectively contributes to CKD progression and cardiovascular damage.

Key Players in the Chronic Kidney Disease Market

The chronic kidney disease market is marked by the presence of major players actively contributing to its growth. Some of the prominent industry players include:

• Pfizer Inc
• Johnson and Johnson Services Inc.
• F. Hoffmann-La Roche Ltd.
• AbbVie Inc.
• Bayer AG
• Novartis International AG
• Sanofi SA
• Bristol-Myers Squibb Company
• Abbott Laboratories Inc.

Chronic Kidney Disease Market Segmentation

The chronic kidney disease market is intricately divided into several segments, including:

1. By Diagnosis: This category includes various methods like blood tests, urine tests, imaging tests, and kidney biopsies for diagnosing CKD.
2. By Treatment: It encompasses a range of treatment options, including drugs, dialysis, kidney transplants, ACE inhibitors, blood tests, and other alternatives.
3. By Route of Administration: Treatments can be administered orally, intravenously, or subcutaneously, with the choice depending on individual patient needs.
4. By End-User: The stakeholders in CKD management are diverse, including hospitals, clinics, ambulatory surgery centers (ASCs), dialysis centers, and other end-users.

Regional Insights
As of 2022, North America led the CKD market. Nevertheless, Asia-Pacific is expected to emerge as the fastest-growing region during the forecast period.
The innovations in product offerings, the influx of novel treatments, and the industry’s emphasis on providing effective and efficient healthcare solutions will go a long way in enhancing the quality of life for those afflicted with CKD.

View More On The Chronic Kidney Disease Market Report 2023 – https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Request A Sample Of The Global Chronic Kidney Disease Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=11969&type=smp

The Chronic Kidney Disease Global Market Report 2023  provides an in-depth analysis on the chronic kidney disease market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the chronic kidney disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Chronic Pain Global Market Report 2023
Diabetic Kidney Disease Global Market Report 2023
Kidney Disease Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model